Brii Biosciences Limited Stock Probability of Future Pink Sheet Price Finishing Under 0.13
| BRIBF Stock | USD 0.13 0.00 0.00% |
Brii |
Brii Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Brii Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Brii Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Brii Biosciences generated a negative expected return over the last 90 days | |
| Brii Biosciences has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (4.16 B) with profit before overhead, payroll, taxes, and interest of 92.54 M. | |
| Brii Biosciences Limited has accumulated about 3.22 B in cash with (879.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: ADAG Stock Surges Amidst Biotech Sector Growth |
Brii Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Brii Pink Sheet often depends not only on the future outlook of the current and potential Brii Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brii Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 720.1 M |
Brii Biosciences Technical Analysis
Brii Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Brii Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Brii Biosciences Limited. In general, you should focus on analyzing Brii Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Brii Biosciences Predictive Forecast Models
Brii Biosciences' time-series forecasting models is one of many Brii Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Brii Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Brii Biosciences
Checking the ongoing alerts about Brii Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Brii Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Brii Biosciences generated a negative expected return over the last 90 days | |
| Brii Biosciences has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (4.16 B) with profit before overhead, payroll, taxes, and interest of 92.54 M. | |
| Brii Biosciences Limited has accumulated about 3.22 B in cash with (879.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: ADAG Stock Surges Amidst Biotech Sector Growth |
Other Information on Investing in Brii Pink Sheet
Brii Biosciences financial ratios help investors to determine whether Brii Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brii with respect to the benefits of owning Brii Biosciences security.